KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition
deficiency induces glucose dependency in lung cancer cells and uncover a therapeutically relevant metabolic liability.
deficiency induces glucose dependency in lung cancer cells and uncover a therapeutically relevant metabolic liability.